ZDBF2: A Potential Drug Target and Biomarker (G57683)

Target Name: ZDBF2

NCBI ID: G57683

ZDBF2

ZDBF2: A Potential Drug Target and Biomarker

Zinc finger proteins (ZFPs) are a family of non-coding RNAs that play a crucial role in various cellular processes. One of the ZFPs, ZDBF2 (DBF4-type zinc finger-containing protein 2), has been identified as a potential drug target and biomarker. This protein is expressed in various tissues and has been shown to play a role in various cellular processes, including cell growth, differentiation, and inflammation.

The ZDBF2 protein is a 21-kDa protein that contains a zinc finger domain and a characteristic N-terminal domain. The zinc finger domain is a well- conserved region that is known to play a role in the regulation of various cellular processes, including gene expression, DNA replication, and protein stability. The N-terminal domain is a unique region that is involved in protein-protein interactions and has been shown to play a role in the regulation of cellular processes, including cell signaling and inflammation.

ZDBF2 has been shown to play a role in various cellular processes, including cell growth, differentiation, and inflammation. For example, ZDBF2 has been shown to be involved in the regulation of cell cycle progression, with studies showing that it promotes the G1 phase and inhibits the S-phase. This suggests that ZDBF2 may play a role in the regulation of cell growth and differentiation.

In addition to its role in cell growth and differentiation, ZDBF2 has also been shown to play a role in the regulation of inflammation. For example, studies have shown that ZDBF2 is involved in the regulation of inflammation and that it has anti-inflammatory effects. This suggests that ZDBF2 may be a potential drug target for the treatment of various inflammatory disorders.

The ZDBF2 protein is also a potential biomarker for various diseases, including cancer. For example, studies have shown that ZDBF2 is expressed in various types of cancer, including breast cancer, lung cancer, and colorectal cancer. This suggests that ZDBF2 may be a potential biomarker for the diagnosis and treatment of various types of cancer.

In conclusion, ZDBF2 is a protein that has been shown to play a role in various cellular processes, including cell growth, differentiation, and inflammation. It is also a potential drug target and biomarker for various diseases, including cancer. Further research is needed to fully understand the role of ZDBF2 in these processes and to develop effective treatments.

Protein Name: Zinc Finger DBF-type Containing 2

The "ZDBF2 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ZDBF2 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets